featured
ASCO 2018: A Review of Current and Upcoming Data on Neoadjuvant Immunotherapy for Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: